• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $FB

    Meta Platforms Inc.

    Subscribe to $FB
    $FB
    Internet and Information Services
    Technology

    Facebook, Inc. develops products that enable people to connect and share with friends and family through mobile devices, personal computers, virtual reality headsets, and in-home devices worldwide. The company's products include Facebook that enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers; Instagram, a community for sharing photos, videos, and private messages; Messenger, a messaging application for people to connect with friends, family, groups, and businesses across platforms and devices; and WhatsApp, a messaging application that is used by people and businesses to communicate in a private way. It also provides Facebook Reality Labs, an augmented and virtual reality product that help people feel connected, anytime, and anywhere. Facebook, Inc. was founded in 2004 and is headquartered in Menlo Park, California.

    IPO Year: 2012

    Exchange: NASDAQ

    Website: investor.fb.com

    Peers

    $SPT

    Recent Analyst Ratings for Meta Platforms Inc.

    DatePrice TargetRatingAnalyst
    4/20/2022$258.00 → $300.00Neutral → Buy
    Citigroup
    4/19/2022$228.00Neutral
    Rosenblatt
    3/11/2022$265.00Buy
    Deutsche Bank
    3/8/2022$301.00 → $240.00Neutral
    Piper Sandler
    3/2/2022$360.00 → $325.00Overweight
    Morgan Stanley
    3/1/2022Hold
    Benchmark
    3/1/2022Hold
    The Benchmark Company
    2/8/2022$270.00Outperform → Neutral
    KGI Securities
    2/4/2022Buy → Hold
    Argus
    2/4/2022$400.00 → $300.00Buy
    Rosenblatt
    See more ratings